Galapagos: To the clinic
Mechelen-based biotech Galapagos NV has appointed Walid Abi-Saab to the role of Chief Medical Officer.
Abi-Saab joins from Shire Pharmaceuticals, where he held various clinical development leadership positions, most recently Group Vice President, Global Clinical Development – Therapeutic Area Head, Gastro-intestinal, Endocrinology and Metabolism. Before Shire, the trained psychiatrist led the clinical development activities at Novartis, Abbott Laboratories, and Pfizer.
Biocytogen Co Ltd
Draupnir Bio ApS